×

About Us
Technologies
Programs
- Oncology
- Diabetes
Clinical Trials
Investors
News
Contact

MENU

Events

Stay tuned for replay links from recent industry and investor presentations.

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes.

(877) 774-GNPX (4679)

3300 Bee Cave Road, Suite 650-227 Austin, TX 78746

Quick Links

About Us
Clinical Trials
Investors
Downloads
Press Releases

X
Facebook
LinkedIn

Latest News

Genprex Selected to Present Trial Design of Acclaim-3 Clinical Trial Evaluating Reqorsa® Gene Therapy in Small Cell Lung Cancer at 2025 ASCO Annual Meeting Apr 24
Genprex Announces Research Collaborators’ Abstract Published in Cancer Research Supplement Proceedings Apr 22
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR Annual Meeting Mar 26
Genprex Collaborators Selected to Present Positive Preclinical Data on Diabetes Gene Therapy at the 2025 American Diabetes Association 85th Scientific Sessions Mar 25

Designed and Secured by Barsec

Copyright ©2025 all rights reserved.
Home - Privacy Policy - Terms of Use